No photo of Marshall Mazepa
Contact Expert

View Scopus Profile

Marshall Mazepa

20012024

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Acquired Thrombotic Thrombocytopenic Purpura and Neuropsychologic Complications

Mazepa, M.

ANSWERING TTP FOUNDATION

9/30/19 → 9/29/21

Project: Research project

A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia

Mazepa, M.

KEZAR LIFE SCIENCES, INC

8/20/19 → 8/30/24

Project: Research project

    • A Phase 2, multicenter, randomized, placebo-controlled, doubleblind study in patients with acquired thrombotic thrombocytopenic purpura (aTTP) to evaluate the pharmacokinetics, safety, and efficacy of rADAMTS-13 (SHP655) administered in addition to stand

    Mazepa, M.

    Baxalta US Inc.

    7/1/19 → 7/30/24

    Project: Research project

    • HEM-POWR: Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A

    Mazepa, M.

    BAYER HEALTHCARE PHARMACEUTICALS

    6/17/19 → 6/30/24

    Project: Research project

    • Bayer 20414: A multicenter, non-randomized, open-label, multiple dose escalation study to evaluate thesafety and tolerability of subcutaneous BAY 1093884 in males with hemophilia

    Mazepa, M.

    BAYER HEALTHCARE PHARMACEUTICALS

    3/11/19 → 3/30/24

    Project: Research project

    • Research Output

    Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis

    Raval, J. S., Park, Y. A., Perjar, I., Mazepa, M. A., Vincent, B. G., Ma, A. D. & Rollins-Raval, M. A., Jan 1 2020, In : Journal of clinical apheresis. 35, 1, p. 59-61 3 p.

    Research output: Contribution to journal › Article

    • Endothelial alterations in a canine model of immune thrombocytopenia

    LeVine, D. N., Cianciolo, R. E., Linder, K. E., Bizikova, P., Birkenheuer, A. J., Brooks, M. B., Salous, A. K., Nordone, S. K., Bellinger, D. A., Marr, H., Jones, S. L., Fischer, T. H., Deng, Y., Mazepa, M. & Key, N. S., Jan 2 2019, In : Platelets. 30, 1, p. 88-97 10 p.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    How targeted therapy disrupts the treatment paradigm for acquired TTP: The risks, benefits, and unknowns

    Mazepa, M. A., Masias, C. & Chaturvedi, S., Aug 1 2019, In : Blood. 134, 5, p. 415-420 6 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies

    Mazepa, M. A., Park, Y. A. & Raval, J. S., Oct 2019, In : Transfusion Medicine Reviews. 33, 4, p. 248-255 8 p.

    Research output: Contribution to journal › Review article

    • The top 10 things to know about transfusion medicine before intern year: An evidence-based course for graduating medical students

    Peedin, A. R., Perjar, I., Mazepa, M. A., Rollins-Raval, M. A., Park, Y. A. & Raval, J. S., Jun 1 2019, In : Blood Research. 54, 2, p. 125-130 6 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations